• [(18)F]AlF-CBP imaging of type I collagen for non-invasive monitoring of pulmonary fibrosis in preclinical models
• A Case Report of Central Bronchiectasis in a Poorly Controlled Asthmatic Adolescent With Allergic Bronchopulmonary Aspergillosis and Secondary Spontaneous Pneumothorax
• A clinical study to monitor prescription patterns, clinical outcomes, and adverse drug reactions among patients of various interstitial lung diseases attending respiratory medicine outpatient department at tertiary care hospital in Northern India
• A Non-Metallic Nanozyme Ameliorates Pulmonary Hypertension Through Inhibiting ROS/TGF-beta1 Signaling
• A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study
• A Rare Lung Malignancy in a Case of Systemic Sclerosis
• Accuracy study of Angiotensin 1-7 composite index test to predict pulmonary fibrosis and guide treatment
• Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments
• Antibacterial and antibiofilm effect of Zinc Oxide nanoparticles on P. aeruginosa variants isolated from young patients with cystic fibrosis
• Artificial intelligence-driven volumetric CT outcome score in cystic fibrosis: longitudinal and multicenter validation with/without modulators treatment
• Assessing alternative treatment targets in patients with cystic fibrosis
• Assessing the arrhythmogenic propensity of fibrotic substrate using digital twins to inform a mechanisms-based atrial fibrillation ablation strategy
• Assessing the impact of triiodothyronine treatment on the lung microbiome of mice with pulmonary fibrosis
• Association of Cardiac MRI-derived Aortic Stiffness with Early Stages and Progression of Heart Failure with Preserved Ejection Fraction
• Asthma severity: the patient's point of view
• Attenuation of renal fibrosis in mice due to lack of bombesin receptor-activated protein homologue
• Brazilian Thoracic Society recommendations for the diagnosis and monitoring of asbestos-exposed individuals
• Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients with Fibrotic Interstitial Lung Disease
• Cell-cell interactions and communication dynamics in lung fibrosis
• CKD-497 inhibits NF-kB signaling and ameliorates inflammation and pulmonary fibrosis in ovalbumin-induced asthma and particulate matter-induced airway inflammatory diseases
• Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
• Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis
• Correction to "FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway"Han XD, Yuan T, Zhang JL, et al. FOXO4 peptide targets myofibroblast ameliorates bleomycin-induc
• Correction: Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach
• Correlations between blood vessel distribution, lung function and structural change in idiopathic pulmonary fibrosis
• COVID-19 seropositive donors yield comparable post-lung transplant outcomes
• Cross-tissue organization of myeloid cells in scleroderma and related fibrotic diseases
• Deciphering the role of oxidative stress genes in idiopathic pulmonary fibrosis: a multi-omics mendelian randomization approach
• Deciphering the spatial organization of fibrotic microenvironment in silica particles-induced pulmonary fibrosis
• Definitions of pulmonary exacerbation in people with cystic fibrosis: a scoping review
• Description and first insights on a large genomic biobank of lung transplantation
• Development and validation of a novel questionnaire to describe and assess sensations and triggers associated with refractory and unexplained chronic cough
• Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis
• Elevated Suicide Risk in Idiopathic Pulmonary Fibrosis Patients
• Emerging role of BMPs/BMPR2 signaling pathway in treatment for pulmonary fibrosis
• Enzyme-like nanoparticle-engineered mesenchymal stem cell secreting HGF promotes visualized therapy for idiopathic pulmonary fibrosis in vivo
• Establishment of a stem cell administration imaging method in bleomycin-induced pulmonary fibrosis mouse models
• Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
• Forsythiaside A ameliorates bleomycin-induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis
• GDF11 evokes lung injury, inflammation, and fibrosis in mice through the ALK5-Smad2/3 signaling pathway
• Global research status and trends of interactions between Traditional Chinese medicine and pulmonary fibrosis: A new dawn in treatment
• Heart failure with preserved ejection fraction
• Hermansky-Pudlak Syndrome Type 2: A Case Report on an Ultra-Rare Disorder
• Hermansky-Pudlak Syndrome: A Rare Congenital Disorder With Interstitial Lung Disease
• Higher body mass index was associated with a lower mortality of idiopathic pulmonary fibrosis: a meta-analysis
• Identification of key mitochondria-related genes and their potential crosstalk role with immune pattern in Idiopathic pulmonary fibrosis
• Identification of oxidative stress-related diagnostic markers and immune infiltration features for idiopathic pulmonary fibrosis by bibliometrics and bioinformatics
• Idiopathic pulmonary fibrosis mortality: update on trends in the modern treatment era
• IL-17 Mildly Rescued the Impaired Proliferation of Alveolar Epithelial Cells Induced by LCN2 Overexpression
• Impact of AI-assisted CXR analysis in detecting incidental lung nodules and lung cancers in non-respiratory outpatient clinics
• In a sticky situation: Pro-coagulant properties expand the importance of neutrophil EVs in driving tissue injury
• Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery
• Inhibition of MRTF-A Ameliorates Pathological Remodeling of the Pressure-loaded Right Ventricle
• Innovative Management of Blood Culture-Negative Endocarditis With Pulmonary Septic Emboli in a Patient With a Biventricular Pacemaker and Implantable Cardioverter Defibrillator (BiV-ICD) and Psychosocial Stressors: A Case Report
• KIAA1199/CEMIP knockdown attenuates cardiac remodeling post myocardial infarction by activating TSP4 pathway in mice
• Leveraging insights from cancer to improve tuberculosis therapy
• Literary evidence of the impact of nonbiological risk factors on CRMS/CFSPID: A scoping review
• Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2 Through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2, Open-Label Clinical Trial
• Lung cell transplantation for pulmonary fibrosis
• Material-driven immunomodulation and ECM remodeling reverse pulmonary fibrosis by local delivery of stem cell-laden microcapsules
• Metabolic profiling of idiopathic pulmonary fibrosis in a mouse model: implications for pathogenesis and biomarker discovery
• MNK-driven eIF4E phosphorylation regulates the fibrogenic transformation of mesenchymal cells and chronic lung allograft dysfunction
• NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblasts
• Notch Signaling Is Associated with Pulmonary Fibrosis in Patients with Pigeon Breeder's Lung by Regulating Oxidative Stress
• Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1A
• Outcomes in Black People with Cystic Fibrosis: A Registry Analysis
• Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the 2^nd International Post-Tuberculosis Symposium
• PF127/bleomycin hydrogel promotes subcutaneous extracellular matrix remodeling and fibrosis to construct personalized flaps through the TGFbeta-Col signaling pathway
• Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability
• Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
• Prognostic performance of Krebs von den Lungen-6, surfactant protein A, surfactant protein D levels in the serum and bronchoalveolar lavage fluid in chronic fibrosing interstitial pneumonia: a retrospective study
• Progressive pulmonary fibrosis: a need for real world data to solve real world clinical problems
• Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis
• Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease
• Quantitative imaging methods in combined pulmonary fibrosis and emphysema
• Repeat administration of human umbilical cord mesenchymal stem cells improves left ventricular diastolic function in mice with heart failure with preserved ejection fraction
• Reply to Yu et al.: Elevated Suicide Risk in Idiopathic Pulmonary Fibrosis Patients
• Research progress on the use of Salvia miltiorrhiza Bunge extracts in the treatment of pulmonary diseases
• RIOK2 transcriptionally regulates TRiC and dyskerin complexes to prevent telomere shortening
• Role of TGFβ-producing regulatory T cells in scleroderma and end-stage organ failure
• Salidroside enhances NO bioavailability and modulates arginine metabolism to alleviate pulmonary arterial hypertension
• Secondary immunodeficiency and non-cystic fibrosis bronchiectasis
• Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study
• Sparing of the heart facilitates recovery from cardiopulmonary side effects after thoracic irradiation
• Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2
• Targeting the chromatin remodelling protein Brahma-related gene 1 for intervention of pulmonary fibrosis
• The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators
• The Coronavirus Disease 2019 Pandemic and Time to Diagnosis for Childhood Pulmonary Diseases: Outcomes of a Tertiary Care Center
• The effects of airway disease on the deposition of inhaled drugs
• The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
• The Lymphatic Highway: How Lymphatics Drive Lung Health and Disease
• The Role of Dental-derived Stem Cell-based Therapy and Their Derived Extracellular Vesicles in Post-COVID-19 Syndrome-induced Tissue Damage
• Therapeutic use of fisetin and pirfenidone combination in bleomycin-induced pulmonary fibrosis in adult male albino rats
• TMEM176B Prevents and alleviates bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor beta-Smad signaling
• Transcriptome sequencing reveals non-coding RNAs respond to porcine reproductive and respiratory syndrome virus and <em>Haemophilus parasuis</em> co-infection in Kele piglets
• Tuberostemonine may alleviates proliferation of lung fibroblasts caused by pulmonary fibrosis
• Type I collagen-targeted liposome delivery of Serca2a modulates myocardium calcium homeostasis and reduces cardiac fibrosis induced by myocardial infarction
• Update on the Role of Chest Imaging in Cystic Fibrosis
• Use of pirfenidone in fibrotic interstitial lung diseases and beyond: a review
• Value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in acute exacerbation of fibrosing interstitial lung disease: an individualized treatment protocol based on microbiological evidence